FDA

Latest

A health official holds Lenacapavir, a long‑acting HIV prevention treatment, in Epworth outside the capital Harare, Zimbabwe, February 19, 2026.REUTERS/Philimon Bulawayo
Poverty

Lenacapavir: the HIV Breakthrough Proving Why NIH Funding Matters

Biomedical advances such as lenacapavir depend on years of publicly funded basic research

Tracking the Progress of "Make America Healthy Again"
Governance

Tracking the Progress of "Make America Healthy Again"

A report card for the Trump administration's health agenda based on confirmation hearings and actions taken to date